Industry Sponsored
BME
2025-2026
Fall
Winter
Spring

InfraMed

InfraMed

Summary

InfraMed

Empowering post-stroke recovery with NIR.

THE PROBLEM

Reperfusion
without repair.

Ischemic stroke:

#1Cause of long-term disability.

#2Cause of death worldwide.

Current ischemic stroke thrombectomy procedures successfully remove the occluding blood clot but do not address or restore the downstream tissue and cellular damage caused by prolonged ischemia.

Technical Approach/Methodology

OUR APPROACH

Beyond clot removal.

Our approach uses near-infrared (NIR) light therapy to target ischemic brain tissue and stimulate cellular repair pathways that are not addressed by clot removal alone.

By enhancing mitochondrial function, we aim to support recovery and restore function in damaged regions beyond reperfusion.

Outcomes

Built for stroke workflow.

Current Standard of Care

Thrombectomy

  • Removes clot
  • Restores blood flow
  • No direct neuroprotection
  • Standalone procedure

Previous PBM Approaches

Transcranial NIR

  • Non-invasive delivery
  • Poor tissue penetration
  • Inconsistent energy delivery
  • Failed large-scale efficacy trials

NTX Therapeutics

Localized Intravascular PBM

  • Delivers light directly to target tissue
  • Supports mitochondrial recovery
  • Integrates into thrombectomy workflow
  • Combines reperfusion + protection